Balanitis Xerotica Obliterans |
| Balanitis
xerotica obliterans (BXO) is widely recognized as the male genital
manifestation of lichen sclerosus, a chronic, progressive, sclerosing
inflammatory dermatosis of unclear etiology that most commonly affects
the foreskin, glans, and external urethral meatus in boys, and which
may, when neglected, extend into the peripheral urethra, penile skin,
and scrotum. The condition was first described in the nineteenth
century under the term lichen sclerosus of the glans and prepuce, and
the internationally adopted designation of balanitis xerotica
obliterans was proposed several decades later to capture its three
cardinal features: chronic inflammation of the glans (balanitis), a
whitish, atrophic epithelial appearance (xerotica), and an obliterative
endarteritis. Although initially considered a disease of adulthood, its
occurrence in children was documented by the mid-twentieth century, and
it is now understood to be the leading cause of secondary, pathological
phimosis in the pediatric population, distinguishing it from the far
more common physiological non-retractility of the prepuce that resolves
spontaneously with growth. The true incidence of BXO in children remains difficult to establish. Population-based estimates from several countries place the prevalence at well under one percent of boys, generally in the range of roughly 0.1 to 0.4 percent, although figures differ according to region, circumcision practices, and how rigorously foreskins are submitted for histological examination. When the denominator is restricted to boys undergoing surgery specifically for phimosis, however, the proportion found to have BXO rises dramatically, with reported rates spanning from a small single-digit percentage to well over a third of cases, and in some surgical series approaching or exceeding forty percent. This wide variability reflects differences in diagnostic thresholds, in the routine (or selective) use of histology, and in the degree of clinical vigilance exercised by both referring practitioners and operating surgeons. A recurring theme across the literature is that incidence figures have risen over recent decades, a trend attributed less to a true increase in disease frequency than to greater awareness among clinicians, more consistent histological confirmation, and closer scrutiny of resected foreskins. The average age at diagnosis clusters around seven to nine years, though cases have been reported across the full pediatric age range, and there is ongoing debate about whether the disease is genuinely rarer in children under five years of age or whether it is simply under-recognized in that younger group, since developmental preputial adhesions are a common and usually benign cause of non-retractility at that age. The etiology of BXO remains incompletely understood but is generally regarded as multifactorial, involving genetic predisposition, autoimmune mechanisms, and chronic local irritation, with infectious causes proposed but never convincingly substantiated. Histopathological and molecular studies have identified an infiltrate of autoreactive cytotoxic T lymphocytes, altered extracellular matrix metabolism, and dysregulated expression of cytokines and growth factors involved in fibrosis and tissue remodeling, alongside reduced expression of proteins that normally maintain epithelial integrity. Associations have been reported with atopic disease, obesity, and, less consistently, autoimmune conditions such as thyroiditis, vitiligo, and celiac disease, as well as with mechanical trauma from repeated forceful retraction of the foreskin, a phenomenon reminiscent of the Köbner effect seen in other lichenoid dermatoses. A modest proportion of affected boys also have coexisting hypospadias, and phototype has been suggested as a risk modifier, though the evidence here is mixed and sometimes contradictory. Clinically, the disease typically announces itself as a progressively worsening, secondary phimosis in a foreskin that was previously retractile, often accompanied by ballooning during micturition, dysuria, and, on inspection, a pearly white, sclerotic, circumferential scar at the tip of the prepuce with variable degrees of erythema, fissuring, or telangiectasia. When the glans can be visualized, pallor and thickening of its surface may be evident, and in a meaningful minority of cases the urethral meatus itself is strictured or discolored. Symptom duration before presentation commonly spans several months, and behavioral changes, constipation, or voiding difficulty may be the presenting complaint in younger children who cannot otherwise articulate genital discomfort. Despite this recognizable clinical picture, the correlation between clinical impression and histological confirmation is strikingly inconsistent across studies, with reported concordance ranging from roughly half to nearly ninety percent, and sensitivity of clinical examination alone often falling below fifty percent even when specificity is high. Combining physical findings with a history of recurrent balanitis, urinary tract infection, or coexisting allergic or autoimmune disease substantially improves specificity and positive predictive value, in some analyses approaching certainty, but only at the cost of markedly reduced sensitivity, meaning that a substantial fraction of true cases could be missed if reliance were placed on history and examination alone. This asymmetry underlies the near-universal recommendation that histological examination of the excised foreskin remains essential for definitive diagnosis, since the absence of supportive history or overt scarring cannot reliably exclude the condition, while conversely, a considerable share of foreskins removed on clinical suspicion of BXO ultimately show only nonspecific chronic inflammation rather than the classic changes of hyperkeratosis, basal epidermal atrophy, homogenized subepidermal collagen with edema, loss of elastic fibers, and a band-like lymphocytic infiltrate. At the same time, evidence suggests that general practitioners and other primary referrers continue to struggle with distinguishing pathological from physiological phimosis, resulting in a large proportion of circumcision referrals that prove, on specialist assessment, to be unnecessary, alongside a smaller but persistent problem of over-diagnosis by surgeons that risks subjecting some children to circumcision for healthy or merely inflamed, non-BXO foreskins. Both diagnostic inaccuracy and over-caution carry costs, whether measured in unnecessary procedures, delayed appropriate treatment, or the resource burden on health systems, and this tension has motivated calls for clearer commissioning guidance and continued clinician education. Left untreated or inadequately managed, BXO follows a chronically progressive or relapsing course with scarring, potential contraction of the frenulum, and, in more advanced disease, meatal or urethral stenosis that can produce obstructed flow, acute or chronic urinary retention, and, rarely, retrograde renal damage. Even after treatment, meatal stenosis remains a recognized complication, occurring in a meaningful minority of boys who undergo circumcision, and a smaller proportion require subsequent surgical intervention such as meatotomy, meatoplasty, or, in severe urethral involvement, reconstruction using buccal mucosal grafts. In adulthood, BXO carries a small but non-negligible risk of malignant transformation to squamous cell carcinoma or related lesions, reported in a low single-digit to high single-digit percentage of cases over long latency periods, which underpins recommendations for continued surveillance into adult life. Circumcision with complete resection of the affected foreskin remains the most widely endorsed definitive treatment, generally curative in the great majority of patients and associated with a low rate of phimosis recurrence when performed thoroughly. Nevertheless, growing recognition of the psychological and cultural importance many families place on foreskin preservation has spurred interest in alternatives. Topical corticosteroids, most commonly potent formulations such as betamethasone or mometasone applied twice daily for several weeks, have demonstrated genuine, statistically significant symptomatic improvement in randomized and observational studies, particularly in mild to moderate disease, though efficacy diminishes in severe or long-standing cases and long-term recurrence data remain limited. Topical calcineurin inhibitors such as tacrolimus and pimecrolimus offer a steroid-sparing option with a favorable side-effect profile on mucosal skin, generally reserved as second-line therapy or adjuncts after incomplete response to steroids. Surgical alternatives to full circumcision, notably preputioplasty combined with intralesional triamcinolone injection, have shown comparable patient satisfaction and, in feasibility trials, an acceptable safety profile with no observed increase in meatal stenosis, making them an appealing option for families seeking to avoid complete foreskin removal, although uptake remains limited by unfamiliarity among surgeons and the absence of formal endorsement in existing commissioning guidance. Ultimately, the management of BXO in children requires balancing definitive surgical cure against the desire for foreskin preservation, underpinned by vigilant histological confirmation, structured follow-up to detect meatal and urethral complications early, and long-term surveillance given the disease's chronic and potentially premalignant nature. References: 1. Boksh K, Patwardhan N. Balanitis xerotica obliterans: has its diagnostic accuracy improved with time? JRSM Open. 8(6):2054270417692731. PMCID: PMC5464383, 2017 2. Nguyen ATM, Holland AJA. Balanitis xerotica obliterans: an update for clinicians. Eur J Pediatr. 179(1):9-16, 2020 3. Leganés Villanueva C, Gander R, Royo Gomes G, Ezzeddine Ezzeddine M, López Paredes M, Asensio Llorente M. Treatment of balanitis xerotica obliterans in pediatric patients. Cir Pediatr. 33(2):79-83, 2020 4. Ghidini F, Virgone C, Pulvirenti R, Trovalusci E, Gamba P. Could a careful clinical examination distinguish physiologic phimosis from balanitis xerotica obliterans in children? Eur J Pediatr. 180(2):591-59, 2021 5. Lansdale N, Arthur F, Corbett HJ. Circumcision versus preputioplasty for balanitis xerotica obliterans: a randomised controlled feasibility trial. BJU Int. 128(6):759-765, 2021 6. Gkalonaki I, Anastasakis M, Psarrakou IS, Patoulias I. Balanitis xerotica obliterans: an underestimated cause of secondary phimosis. Folia Med Cracov. 61(4):93-100, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|